Vitrolife Ab Stock Fundamentals
| VITR Stock | SEK 228.60 7.20 3.25% |
Vitrolife AB fundamentals help investors to digest information that contributes to Vitrolife's financial success or failures. It also enables traders to predict the movement of Vitrolife Stock. The fundamental analysis module provides a way to measure Vitrolife's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitrolife stock.
Vitrolife |
Vitrolife AB Company Return On Equity Analysis
Vitrolife's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vitrolife Return On Equity | 0.0246 |
Most of Vitrolife's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitrolife AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vitrolife AB has a Return On Equity of 0.0246. This is 100.1% lower than that of the Biotechnology sector and 100.07% lower than that of the Health Care industry. The return on equity for all Sweden stocks is 107.94% lower than that of the firm.
Vitrolife AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vitrolife's current stock value. Our valuation model uses many indicators to compare Vitrolife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vitrolife competition to find correlations between indicators driving Vitrolife's intrinsic value. More Info.Vitrolife AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.83 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vitrolife AB is roughly 1.20 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitrolife's earnings, one of the primary drivers of an investment's value.Vitrolife Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vitrolife's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vitrolife could also be used in its relative valuation, which is a method of valuing Vitrolife by comparing valuation metrics of similar companies.Vitrolife is currently under evaluation in return on equity category among its peers.
Vitrolife Fundamentals
| Return On Equity | 0.0246 | |||
| Return On Asset | 0.0205 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 28.19 B | |||
| Shares Outstanding | 135.45 M | |||
| Shares Owned By Insiders | 32.02 % | |||
| Shares Owned By Institutions | 43.80 % | |||
| Price To Earning | 58.44 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 8.73 X | |||
| Revenue | 1.68 B | |||
| Gross Profit | 1.78 B | |||
| EBITDA | 576.66 M | |||
| Net Income | 340.97 M | |||
| Cash And Equivalents | 630.09 M | |||
| Cash Per Share | 4.11 X | |||
| Total Debt | 2.03 B | |||
| Debt To Equity | 4.90 % | |||
| Current Ratio | 4.79 X | |||
| Book Value Per Share | 123.61 X | |||
| Cash Flow From Operations | 384.31 M | |||
| Earnings Per Share | 2.57 X | |||
| Price To Earnings To Growth | 3.50 X | |||
| Target Price | 335.0 | |||
| Number Of Employees | 1.07 K | |||
| Beta | 1.49 | |||
| Market Capitalization | 31.97 B | |||
| Total Asset | 19.43 B | |||
| Retained Earnings | 390 M | |||
| Working Capital | 327 M | |||
| Current Asset | 467 M | |||
| Current Liabilities | 140 M | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.56 % | |||
| Net Asset | 19.43 B | |||
| Last Dividend Paid | 0.85 |
About Vitrolife Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitrolife AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitrolife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitrolife AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction. Vitrolife AB was founded in 1981 and is headquartered in Gothenburg, Sweden. Vitrolife operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 415 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitrolife Stock Analysis
When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.